Behrend et al (2013) Diagnosis of Spontaneous Canine Hyperadrenocorticism: 2012 ACVIM Consensus Statement (Small Animal) Journal of Veterinary Internal Medicine 1-13

Macfarlane L., Parkin T. And Ramsey I.K. (2016) Pre-trilostane and 3-hour post-trilostane cortisol to monitor trilostane therapy in dogs. Veterinary Record 179: 597-605

Ramsey I. K., Macfarlane l., Fracassi F., Galac s. & Reusch c. (2016) The repeatability of various cortisol measurements in clinically stable dogs with hyperadrenocorticism being treated with Vetoryl (Abstract) European College of Veterinary Internal Medicine Congress, Gotenburg (published in Journal of Veterinary Internal Medicine 17: 737DO - 10.1111/jvim.14600

Dr. Audrey Cook, BVM&S, Dip ACVIM

Dr. med. vet. Astrid Wehner, Diplomate ECVIM-CA (Internal Medicine), EBVS® European Veterinary Specialist in Small Animal Internal Medicine, Fachtierärztin für Innere Medizin der Kleintiere, Fachgebiet: Innere Medizin, Endokrinologie, Medizinische Kleintierklinik der LMU München

Deborah Dobosz, Tierärztin, Wissenschaftliche Hilfskraft Endokrinologie, Medizinische Kleintierklinik der LMU München

Nagata et al (2017) Comparison of Surival Times for Dogs with Pituritary-Dependent Hyperadrenocorticism in a Primary-Care Hospital: Treated with Trilostane versus Untreated. JVIM 21: 22-28

Wenger et al (2004) Effects of trilostane on serum concentrations of aldosterone, cortisol and potassium in dogs with pituitary-dependent hyperadrenocorticism. AJVR 65(9): 245-50

Vaughan et al (2008) Evaluation of twice-daily, low dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism. JAVMA 232(9): 1321-132

Feldman (2011) Evaluation of twice-daily lower-dose trilostane treatment administered orally in dogs with naturally occurring hyperadrenocorticism. JAVMA 238: 1441-1451

Augusto et al (2012) A comparison of once and twice daily administration of trilostane to dogs with hyperadrenocorticism. Tierarztliche Praxis Kleintiere 40: 415-424

Cho et al (2013) Efficacy of low- and high-dose trilostane treatment in dogs (< 5 kg) with pituitary-dependent hyperadrenocorticism. JVIM 27: 91-98

Internal Report VET0818

Prof. Dr. Katrin Hartmann, Diplomate ECVIM-CA (Internal Medicine), EBVS® European Veterinary Specialist in Small Animal Internal Medicine, Fachtierärztin für Innere Medizin, Fachtierärztin für Innere Medizin der Kleintiere Fachtierärztin für Klinische Laboratoriumsdiagnostik., Klinikleitung, Stellvertretende Direktorin des Zentrums für Klinische Tiermedizin